Energy Failure
暂无分享,去创建一个
Ken Nakamura | D. Pathak | Ken Nakamura | Divya Pathak | Amandine Berthet | A. Berthet | Amandine Berthet
[1] Xiongwei Zhu,et al. LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. , 2012, Human molecular genetics.
[2] R. Youle,et al. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy , 2008, The Journal of cell biology.
[3] R. Youle,et al. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin , 2010, The Journal of cell biology.
[4] M. Feany,et al. Tau Promotes Neurodegeneration via DRP1 Mislocalization In Vivo , 2012, Neuron.
[5] A. Chiarugi. “Simple but not simpler”: toward a unified picture of energy requirements in cell death , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] R. Rodenburg,et al. Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance , 2011, Journal of Cell Science.
[7] Rodrigue Rossignol,et al. Energy Substrate Modulates Mitochondrial Structure and Oxidative Capacity in Cancer Cells , 2004, Cancer Research.
[8] D M Porterfield,et al. The self-referencing oxygen-selective microelectrode: detection of transmembrane oxygen flux from single cells. , 1999, The Journal of experimental biology.
[9] P. E. Gold,et al. Decreases in rat extracellular hippocampal glucose concentration associated with cognitive demand during a spatial task. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[10] Nobuhiko Ohno,et al. Myelination and Axonal Electrical Activity Modulate the Distribution and Motility of Mitochondria at CNS Nodes of Ranvier , 2011, The Journal of Neuroscience.
[11] D. Manners,et al. Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy , 2000, Annals of neurology.
[12] W. Lieberthal,et al. Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells. , 1998, American journal of physiology. Renal physiology.
[13] R. Palmiter,et al. Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson’s disease model , 2011, The Journal of cell biology.
[14] A. Munnich,et al. Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency , 2000, The Lancet.
[15] Carola Seifried,et al. Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease. , 2009, Brain : a journal of neurology.
[16] G. Ronnett,et al. Physiological oxygen level is critical for modeling neuronal metabolism in vitro , 2012, Journal of neuroscience research.
[17] Arne Schousboe,et al. Compartmentation of Glutamine, Glutamate, and GABA Metabolism in Neurons and Astrocytes: Functional Implications , 2003, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[18] I. Reynolds,et al. Mitochondrial Trafficking to Synapses in Cultured Primary Cortical Neurons , 2006, The Journal of Neuroscience.
[19] P. Verstreken,et al. Synaptic Mitochondria Are Critical for Mobilization of Reserve Pool Vesicles at Drosophila Neuromuscular Junctions , 2005, Neuron.
[20] K. Kashihara. Weight loss in Parkinson’s disease , 2006, Journal of Neurology.
[21] Takeharu Nagai,et al. Visualization of ATP levels inside single living cells with fluorescence resonance energy transfer-based genetically encoded indicators , 2009, Proceedings of the National Academy of Sciences.
[22] M. J. Arnold,et al. Glucose dependence of glycolysis, hexose monophosphate shunt activity, energy status, and the polyol pathway in retinas isolated from normal (nondiabetic) rats. , 1997, Investigative ophthalmology & visual science.
[23] D. Blum,et al. 3‐Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease , 2005, Journal of neurochemistry.
[24] Paul T. Schumacker,et al. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1 , 2010, Nature.
[25] Atsushi Tanaka,et al. PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin , 2010, PLoS biology.
[26] Douglass M. Turnbull,et al. Does the mitochondrial genome play a role in the etiology of Alzheimer’s disease? , 2006, Human Genetics.
[27] Frederico A. C. Azevedo,et al. Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled‐up primate brain , 2009, The Journal of comparative neurology.
[28] Angela C. Poole,et al. The PINK1/Parkin pathway regulates mitochondrial morphology , 2008, Proceedings of the National Academy of Sciences.
[29] Manuel B. Graeber,et al. PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease , 2010, Science Translational Medicine.
[30] HighWire Press. The journal of neuroscience : the official journal of the Society for Neuroscience. , 1981 .
[31] John X. Morris,et al. Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition , 2010, Proceedings of the National Academy of Sciences.
[32] F Gonzalez-Lima,et al. Energy Hypometabolism in Posterior Cingulate Cortex of Alzheimer's Patients: Superficial Laminar Cytochrome Oxidase Associated with Disease Duration , 2001, The Journal of Neuroscience.
[33] H. Savolainen. Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial , 2006, Neurology.
[34] S. Koifman,et al. Pesticide exposure and Parkinson's disease: epidemiological evidence of association. , 2012, Neurotoxicology.
[35] L. Massieu,et al. Neurotoxicity of glutamate uptake inhibition in vivo: correlation with succinate dehydrogenase activity and prevention by energy substrates , 2001, Neuroscience.
[36] Xin Li,et al. α-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity , 2009, Neuroscience Letters.
[37] J. Langston,et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.
[38] G. Brewer,et al. Mitoenergetic failure in Alzheimer disease. , 2007, American journal of physiology. Cell physiology.
[39] A. Schousboe,et al. Novel model of neuronal bioenergetics: postsynaptic utilization of glucose but not lactate correlates positively with Ca2+ signalling in cultured mouse glutamatergic neurons , 2012, ASN neuro.
[40] Ann Saada,et al. The Transgenic Overexpression of α-Synuclein and Not Its Related Pathology Associates with Complex I Inhibition* , 2010, The Journal of Biological Chemistry.
[41] J. Buxbaum,et al. PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia. , 2009, Archives of neurology.
[42] F. Fujiyama,et al. Single Nigrostriatal Dopaminergic Neurons Form Widely Spread and Highly Dense Axonal Arborizations in the Neostriatum , 2009, The Journal of Neuroscience.
[43] Min Wu,et al. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. , 2007, American journal of physiology. Cell physiology.
[44] J. Greene,et al. Characterization of the Excitotoxic Potential of the Reversible Succinate Dehydrogenase Inhibitor Malonate , 1995, Journal of neurochemistry.
[45] S. Moncada,et al. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C–Cdh1 , 2009, Nature Cell Biology.
[46] Andrea Ciarmiello,et al. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[47] N. Bonini,et al. DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function , 2010, Proceedings of the National Academy of Sciences.
[48] R. Burke,et al. Clinical progression in Parkinson disease and the neurobiology of axons , 2010, Annals of neurology.
[49] Changan Jiang,et al. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin , 2006, Nature.
[50] M. Beal. Faculty Opinions recommendation of S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. , 2009 .
[51] R. Hamilton,et al. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease , 2009, Proceedings of the National Academy of Sciences.
[52] S. Sisodiya,et al. Mitochondrial ND5 Gene Variation Associated with Encephalomyopathy and Mitochondrial ATP Consumption* , 2007, Journal of Biological Chemistry.
[53] D. Bennett,et al. Change in body mass index and risk of incident Alzheimer disease , 2005, Neurology.
[54] R. Nussbaum,et al. Direct Membrane Association Drives Mitochondrial Fission by the Parkinson Disease-associated Protein α-Synuclein*♦ , 2011, The Journal of Biological Chemistry.
[55] J. Milbrandt,et al. Mitofusin2 Mutations Disrupt Axonal Mitochondrial Positioning and Promote Axon Degeneration , 2012, The Journal of Neuroscience.
[56] B. Landwehrmeyer,et al. Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.
[57] G. Shepherd,et al. Three-Dimensional Structure and Composition of CA3→CA1 Axons in Rat Hippocampal Slices: Implications for Presynaptic Connectivity and Compartmentalization , 1998, The Journal of Neuroscience.
[58] Douglas R. Porter,et al. Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice , 2007, Proceedings of the National Academy of Sciences.
[59] M. Beal,et al. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[60] M. Beal,et al. Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders , 2001, Annals of neurology.
[61] George Perry,et al. Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease , 2009, The Journal of Neuroscience.
[62] J. Nunnari,et al. Mitochondria: In Sickness and in Health , 2012, Cell.
[63] K. Marder,et al. Weight loss in early stage of Huntington’s disease , 2002, Neurology.
[64] S. Dimauro,et al. Phenotype–genotype correlations in skeletal muscle of patients with mtDNA deletions , 1995, Muscle & nerve. Supplement.
[65] R. Palmiter,et al. Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat , 2008, Proceedings of the National Academy of Sciences.
[66] G. Petzinger,et al. The parkinsonian toxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP): a technical review of its utility and safety , 2001, Journal of neurochemistry.
[67] H. Engler,et al. Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease , 2012, Neurobiology of Aging.
[68] A. Godzik,et al. S-Nitrosylation of Drp1 Mediates β-Amyloid-Related Mitochondrial Fission and Neuronal Injury , 2009, Science.
[69] Robert W. Taylor,et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease , 2006, Nature Genetics.
[70] Jens Frahm,et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity , 2012, Nature.
[71] Sunhong Kim,et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin , 2006, Nature.
[72] Kewei Chen,et al. Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[73] P. Verstreken,et al. Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function , 2009, EMBO molecular medicine.
[74] Janaka N. Edirisinghe,et al. Vitamin K2 Is a Mitochondrial Electron Carrier That Rescues Pink1 Deficiency , 2012, Science.
[75] C. Marsden,et al. Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's Disease , 1990, Journal of neurochemistry.
[76] Xinnan Wang,et al. PINK1 and Parkin Target Miro for Phosphorylation and Degradation to Arrest Mitochondrial Motility , 2011, Cell.
[77] W. Frommer,et al. GLUT1 and GLUT9 as major contributors to glucose influx in HepG2 cells identified by a high sensitivity intramolecular FRET glucose sensor. , 2008, Biochimica et biophysica acta.
[78] H. Fox,et al. Oxygen matters: tissue culture oxygen levels affect mitochondrial function and structure as well as responses to HIV viroproteins , 2011, Cell Death and Disease.
[79] Fanny Mochel,et al. Energy deficit in Huntington disease: why it matters. , 2011, The Journal of clinical investigation.
[80] Pravat K. Mandal,et al. Magnetic Resonance Spectroscopy (MRS) and Its Application in Alzheimer's Disease , 2007 .
[81] A. Rex,et al. Stimulus-dependent changes of extracellular glucose in the rat hippocampus determined by in vivo microdialysis , 2009, Physiology & Behavior.
[82] A. Bacci,et al. Lack of association between mtDNA haplogroups and Alzheimer’s disease in Tuscany , 2007, Neurological Sciences.
[83] T. Dawson,et al. PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease , 2011, Cell.
[84] Winnie S. Liang,et al. Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons , 2008, Proceedings of the National Academy of Sciences.
[85] D. Chan,et al. Disruption of Fusion Results in Mitochondrial Heterogeneity and Dysfunction* , 2005, Journal of Biological Chemistry.
[86] T. Patterson,et al. Gene expression profiling of MPP+-treated MN9D cells: a mechanism of toxicity study. , 2007, Neurotoxicology.
[87] W. Watt,et al. Mice with mitochondrial complex I deficiency develop a fatal encephalomyopathy. , 2008, Cell metabolism.
[88] F. Schmitt,et al. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment , 2007, Neurology.
[89] A. Ames,et al. Energy metabolism of rabbit retina as related to function: high cost of Na+ transport , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[90] B. Frenguelli,et al. Mitochondrial Membrane Potential and Glutamate Excitotoxicity in Cultured Cerebellar Granule Cells , 2000, The Journal of Neuroscience.
[91] Jim Berg,et al. A genetically encoded fluorescent reporter of ATP/ADP ratio , 2008, Nature Methods.
[92] Dimitri Krainc,et al. Transcriptional Repression of PGC-1α by Mutant Huntingtin Leads to Mitochondrial Dysfunction and Neurodegeneration , 2006, Cell.
[93] Michael R. Duchen,et al. PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-Induced Cell Death , 2009, Molecular cell.
[94] Shanta M. Messerli,et al. Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase , 2011, Nature Cell Biology.
[95] B R Rosen,et al. 1H NMR spectroscopy studies of Huntington's disease , 1998, Neurology.
[96] Elsa Lauwers,et al. Frontiers in Synaptic Neuroscience Synaptic Neuroscience , 2022 .
[97] S. Snyder,et al. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[98] J. Milbrandt,et al. Aberrant Schwann Cell Lipid Metabolism Linked to Mitochondrial Deficits Leads to Axon Degeneration and Neuropathy , 2013, Neuron.
[99] Victor S. Van Laar,et al. The interplay of neuronal mitochondrial dynamics and bioenergetics: Implications for Parkinson's disease , 2013, Neurobiology of Disease.
[100] Ted M. Dawson,et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy , 2009, Proceedings of the National Academy of Sciences.
[101] Bradford C. Dickerson,et al. Regional Expansion of Hypometabolism in Alzheimer's Disease Follows Amyloid Deposition with Temporal Delay , 2012, Biological Psychiatry.
[102] Todd B. Sherer,et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.
[103] R. Schiffmann,et al. Early Alterations of Brain Cellular Energy Homeostasis in Huntington Disease Models* , 2011, The Journal of Biological Chemistry.
[104] S. Przedborski,et al. Is there a pathogenic role for mitochondria in Parkinson's disease? , 2009, Parkinsonism & related disorders.
[105] Tamara Sotelo-Hitschfeld,et al. High Resolution Measurement of the Glycolytic Rate , 2010, Front. Neuroenerg..
[106] V. Choubey,et al. Mutant A53T α-Synuclein Induces Neuronal Death by Increasing Mitochondrial Autophagy* , 2011, The Journal of Biological Chemistry.
[107] M. Brand,et al. Assessing mitochondrial dysfunction in cells , 2011, The Biochemical journal.
[108] C. Schade-Brittinger,et al. In vivo Evidence for Cerebral Depletion in High-Energy Phosphates in Progressive Supranuclear Palsy , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[109] M. Walker,et al. Prolonged seizure activity impairs mitochondrial bioenergetics and induces cell death , 2011, Journal of Cell Science.
[110] Armin Giese,et al. Inhibition of mitochondrial fusion by α‐synuclein is rescued by PINK1, Parkin and DJ‐1 , 2010, The EMBO journal.
[111] Abnormal response to cortical activation in early stages of Huntington disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[112] Thomas W von Geldern,et al. Faculty Opinions recommendation of Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. , 2011 .
[113] R. Margreiter,et al. Heterogeneity of Mitochondria and Mitochondrial Function within Cells as Another Level of Mitochondrial Complexity , 2009, International journal of molecular sciences.
[114] G. Alexander,et al. Correlations between apolipoprotein E ε4 gene dose and brain-imaging measurements of regional hypometabolism , 2005 .
[115] H. Braak,et al. Poor and protracted myelination as a contributory factor to neurodegenerative disorders , 2004, Neurobiology of Aging.
[116] Janet S. Reddin,et al. Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease , 2012, Alzheimer's & Dementia.
[117] T. Videen,et al. Selective defect of in vivo glycolysis in early Huntington's disease striatum , 2007, Proceedings of the National Academy of Sciences.
[118] Dimitrios Kapogiannis,et al. Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease , 2011, The Lancet Neurology.
[119] L. Reitzer,et al. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. , 1979, The Journal of biological chemistry.
[120] H. Westerblad,et al. Increased mitochondrial mass in mitochondrial myopathy mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[121] Jayne E. Telford,et al. Complex I Is Rate-limiting for Oxygen Consumption in the Nerve Terminal* , 2009, Journal of Biological Chemistry.
[122] H Li,et al. Huntingtin Aggregate-Associated Axonal Degeneration is an Early Pathological Event in Huntington's Disease Mice , 2001, The Journal of Neuroscience.
[123] W. Shan,et al. Rapid method for culturing embryonic neuron–glial cell cocultures , 2003, Journal of neuroscience research.
[124] A. Singleton,et al. A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease. , 2009, American journal of human genetics.
[125] J. Kordower,et al. Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease. , 2012, Brain : a journal of neurology.
[126] R. Nussbaum,et al. Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.
[127] M. Beal,et al. Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery , 2008, Proceedings of the National Academy of Sciences.
[128] S. Tabrizi,et al. Biochemical abnormalities and excitotoxicity in Huntington's disease brain , 1999, Annals of neurology.
[129] G. Sinclair,et al. Guanidinoacetate methyltransferase deficiency: first steps to newborn screening for a treatable neurometabolic disease. , 2012, Molecular genetics and metabolism.
[130] D. Turnbull,et al. Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis. , 2011, Brain : a journal of neurology.
[131] Ian J. Reynolds,et al. Spontaneous Changes in Mitochondrial Membrane Potential in Cultured Neurons , 2001, The Journal of Neuroscience.